Oragenics Inc (OGEN)
0.3289
-0.01
(-3.26%)
USD |
NYAM |
Nov 14, 16:00
0.3289
0.00 (0.00%)
After-Hours: 20:00
Oragenics Cash and Short Term Investments (Quarterly): 1.349M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.349M |
| March 31, 2024 | 2.072M |
| December 31, 2023 | 3.484M |
| September 30, 2023 | 5.767M |
| June 30, 2023 | 6.474M |
| March 31, 2023 | 9.158M |
| December 31, 2022 | 11.43M |
| September 30, 2022 | 13.95M |
| June 30, 2022 | 17.87M |
| March 31, 2022 | 21.37M |
| December 31, 2021 | 27.27M |
| September 30, 2021 | 29.95M |
| June 30, 2021 | 34.57M |
| March 31, 2021 | 36.50M |
| December 31, 2020 | 17.64M |
| September 30, 2020 | 10.04M |
| June 30, 2020 | 9.629M |
| March 31, 2020 | 14.37M |
| December 31, 2019 | 18.27M |
| September 30, 2019 | 22.29M |
| June 30, 2019 | 25.72M |
| March 31, 2019 | 29.35M |
| December 31, 2018 | 20.21M |
| September 30, 2018 | 13.81M |
| June 30, 2018 | 3.940M |
| Date | Value |
|---|---|
| March 31, 2018 | 4.758M |
| December 31, 2017 | 6.166M |
| September 30, 2017 | 2.924M |
| June 30, 2017 | 2.089M |
| March 31, 2017 | 2.175M |
| December 31, 2016 | 4.081M |
| September 30, 2016 | 5.117M |
| June 30, 2016 | 5.457M |
| March 31, 2016 | 3.368M |
| December 31, 2015 | 5.083M |
| September 30, 2015 | 6.739M |
| June 30, 2015 | 8.044M |
| March 31, 2015 | 9.054M |
| December 31, 2014 | 10.45M |
| September 30, 2014 | 11.76M |
| June 30, 2014 | 12.90M |
| March 31, 2014 | 14.64M |
| December 31, 2013 | 16.28M |
| September 30, 2013 | 8.268M |
| June 30, 2013 | 6.368M |
| March 31, 2013 | 8.350M |
| December 31, 2012 | 9.926M |
| September 30, 2012 | 11.76M |
| June 30, 2012 | 1.130M |
| March 31, 2012 | 0.9679M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.349M
Minimum
Jun 2024
36.50M
Maximum
Mar 2021
15.32M
Average
13.95M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | 2.339M |
| Perspective Therapeutics Inc | 292.87M |
| Alaunos Therapeutics Inc | 2.463M |
| Cocrystal Pharma Inc | 18.14M |
| Cara Therapeutics Inc | 56.62M |